ranibizumab
OHR-004
Phase 2 small_molecule completed
Quick answer
ranibizumab for Retinal Vein Occlusion is a Phase 2 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CUMBERLAND PHARMACEUTICALS INC
- Indication
- Retinal Vein Occlusion
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed